Emergency LP in a patient receiving dabigatran after antagonization with idarucizumab

Autor:	Christian H. Nolte, Christoph C. Eschenfelder, Tim Bastian Braemswig
Rok vydání:	2016
Předmět:	Male medicine.drug_class Antidotes Hemorrhage 030204 cardiovascular system & hematology Antibodies Monoclonal Humanized Spinal Puncture Antithrombins Dabigatran 03 medical and health sciences 0302 clinical medicine X ray computed Atrial Fibrillation Aphasia Medicine Humans Carotid Stenosis Ultrasonography Aged 80 and over Endarterectomy Carotid medicine.diagnostic_test business.industry Lumbar puncture Anticoagulant Idarucizumab Infarction Middle Cerebral Artery General Medicine Magnetic Resonance Imaging Anesthesia Emergency Medicine Emergencies business Emergency Service Hospital Tomography X-Ray Computed 030217 neurology & neurosurgery medicine.drug
Zdroj:	The American journal of emergency medicine. 35(4)
ISSN:	1532-8171
Popis:	Idarucizumab is an antibody fragment which is used to reverse the anticoagulant effects of dabigatran. We report on the first successful use of idarucizumab before performing an emergency lumbar puncture in a patient on effective anticoagulation with dabigatran thought to have infective cerebral disease (such as temporal encephalitis).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d0c9fcf88f7b862243225ddf43cb44b https://pubmed.ncbi.nlm.nih.gov/27836320 Zobrazit plný text záznamu Full Text from ScienceDirect